<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02946723</url>
  </required_header>
  <id_info>
    <org_study_id>PINS-022</org_study_id>
    <nct_id>NCT02946723</nct_id>
  </id_info>
  <brief_title>A Study to Compare the Efficacy and Safety of Ultrasound Guided Lead Implantation for Sacral Neuromodulation (SNM) in Subjects With Overactive Bladder (OAB) With X-Ray Guided Technique</brief_title>
  <official_title>A Study to Compare the Efficacy and Safety of Ultrasound Guided Lead Implantation for Sacral Neuromodulation (SNM) in Subjects With Overactive Bladder (OAB)With X-Ray Guided Technique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Pins Medical Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Pins Medical Co., Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Overactive bladder(OAB,Urgency) was determined by International Continence Society as Urinary&#xD;
      urgency, usually accompanied by frequency and nocturia, with or without urgency urinary&#xD;
      incontinence, in the absence of urinary tract infection (UTI) or other obvious pathology.The&#xD;
      SNM treatment involves a two-stage surgical procedure performed under local anesthesia. The&#xD;
      device include IPG (implantable programme generator) and lead. In the initial test phase, 1st&#xD;
      stage, electrode is placed near the sacral nerve and requires a 2 weeks assessment. This&#xD;
      allows your doctors and you to assess your initial response according to your voiding dairy&#xD;
      and satisfaction. In 2nd stage, SNM procedure is implantation of the IPG.&#xD;
&#xD;
      X ray guidance is harmful to both patients and doctors, while ultrasound guidance is real&#xD;
      time visual guidance ,easy to operate by doctors and a radiation free option to challenge&#xD;
      anatomy. Urologists are skilled in both ultrasound operations and anatomy basics and&#xD;
      dedicating to developing better guidance technique in surgery.&#xD;
&#xD;
      The study here compare the efficacy and safety of ultrasound versus X ray guidance technique&#xD;
      in SNM.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2017</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Successful rate</measure>
    <time_frame>6 months post -IPG implantation</time_frame>
    <description>Successful rate is the percentage of patients who experienced a successful result (â‰¥50% improvements in baseline symptoms ) as recorded in voiding dairies.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse effect</measure>
    <time_frame>During operation, 2 weeks post-lead implantation, 3 and 6 months post -IPG implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Guidance technique performance time</measure>
    <time_frame>From beginning operation until successful lead placement is completed</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Times of X-ray radiation</measure>
    <time_frame>During operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overactive bladder symptom score (OABSS)</measure>
    <time_frame>pre-operation baseline, 2 weeks post-lead implantation, 3 and 6 months post -IPG implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (QoL) scores</measure>
    <time_frame>pre-operation baseline, 2 weeks post-lead implantation, 3 and 6 months post -IPG implantation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Refractory Overactive Bladder</condition>
  <arm_group>
    <arm_group_label>US group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>lead implantation surgery for SNM using ultrasound guided technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>X-ray group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>lead implantation surgery for SNM using X-ray guided technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ultrasound</intervention_name>
    <description>Lead implantation surgery for SNM using ultrasound guided technique</description>
    <arm_group_label>US group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>X-ray</intervention_name>
    <description>Lead implantation surgery for SNM using X-ray technique</description>
    <arm_group_label>X-ray group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age &gt; 16 years;&#xD;
&#xD;
          2. Subjects suitable for SNM surgery;&#xD;
&#xD;
          3. Normal upper urinary tract function;&#xD;
&#xD;
          4. Bladder volume &gt; 100 mL;&#xD;
&#xD;
          5. Good compliance and able to complete the follow-up assessments.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Psychiatric or neurologic disabilities on neurologic evaluation such as multiple&#xD;
             sclerosis, spinal cord injury, epilepsy, Parkinson's disease, stroke;&#xD;
&#xD;
          2. Bladder lithiasis or tumor (cystoscopy or ultrasonography);&#xD;
&#xD;
          3. Stress urinary incontinence;&#xD;
&#xD;
          4. Bladder outlet obstruction;&#xD;
&#xD;
          5. Diuresis &gt; 3 liters per 24 hours;&#xD;
&#xD;
          6. Negative at the test period or previous treatment with SNM;&#xD;
&#xD;
          7. Pregnancy and plan to be pregnancy in 2 years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fumin Jia, PhD</last_name>
    <phone>010-59361265</phone>
    <email>pins_medical@163.con</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luming Li</last_name>
    <phone>010-60736388</phone>
  </overall_contact_backup>
  <verification_date>October 2016</verification_date>
  <study_first_submitted>October 25, 2016</study_first_submitted>
  <study_first_submitted_qc>October 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2016</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder, Overactive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

